Oleate protects against palmitate-induced insulin resistance in L6 myotubes.

School of Life and Health Sciences, Aston University, Birmingham, UK.
The British journal of nutrition (Impact Factor: 3.34). 08/2009; 102(11):1557-63. DOI: 10.1017/S0007114509990948
Source: PubMed

ABSTRACT Oleate has been shown to protect against palmitate-induced insulin resistance. The present study investigates mechanisms involved in the interaction between oleate and palmitate on insulin-stimulated glucose uptake by L6 skeletal muscle cells. L6 myotubes were cultured for 6 h with palmitate or oleate alone, and combinations of palmitate with oleate, with and without phosphatidylinositol 3-kinase (PI3-kinase) inhibition. Insulin-stimulated glucose uptake, measured by uptake of 2-deoxy-d-[3H]glucose, was almost completely prevented by 300 microm-palmitate. Cells incubated with oleate up to 750 micromol/l maintained a significant increase in insulin-stimulated glucose uptake. Co-incubation of 50-300 microm-oleate with 300 microm-palmitate partially prevented the decrease in insulin-stimulated glucose uptake associated with palmitate. Adding the PI3-kinase inhibitors wortmannin (10- 7 mol/l) or LY294002 (25 micromol/l) to 50 microm-oleate plus 300 microm-palmitate significantly reduced the beneficial effect of oleate against palmitate-induced insulin resistance, indicating that activation of PI3-kinase is involved in the protective effect of oleate. Thus, the prevention of palmitate-induced insulin resistance by oleate in L6 muscle cells is associated with the ability of oleate to maintain insulin signalling through PI3-kinase.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The effect of conjugated linoleic acid (CLA) on insulin resistance (IR) was isomer specific. In the present study, we induced IR Chang liver cells by incubating cells with 100 nmol/L insulin for 24 h. Then the effect of trans10, cis12‐conjugated linoleic acid (t10, c12‐CLA) and cis9, trans11‐conjugated linoleic acid (c9, t11‐CLA) on IR cells were studied. 1 µmol/L, 2 µmol/L, 5 µmol/L and 10 µmol/L t10, c12‐CLA, but not c9, t11‐CLA were found to enhance glucose consumption of IR cells in a dose‐dependent way. 2 µmol/L t10, c12‐CLA for 12 h incubation significantly improved glucose consumption of IR cells and increased phospho‐protein kinase B (p‐PKB/p‐Akt) protein level. The enhancement of glucose consumption of IR cells by t10, c12‐CLA and the level of p‐Akt was strongly inhibited by phosphatidylinositol 3‐kinase (PI3K) inhibitor LY294002, indicating that PI3K/Akt insulin signaling pathway may be involved in the beneficial effect of t10, c12‐CLA on alleviating IR. PRACTICAL APPLICATIONThe intake of dairy foods has been shown to be relevant with type 2 diabetes in various conditions. A potential group of biologically active compounds that attracted lots of attention these years to explain this effect might be CLA. However, the potential effect of CLA on diabetes is isomer‐specific, thus, the study performed on pure CLA isomer is important to make the issue clearly. In the current study, we focused on the effect of pure t10, c12‐CLA and c9, t11‐CLA on IR, key characteristics of type 2 diabetes. The results show that t10, c12‐CLA, rather than c9, t11‐CLA improved the glucose uptake and utilization, suggesting a beneficial effect of t10, c12‐CLA on alleviating type 2 diabetes. This conclusion may be of help in the research and development of functional food and pharmaceuticals rich in t10, c12‐CLA for the therapy of IR and type 2 diabetes.
    Journal of Food Biochemistry 12/2011; 35(6). DOI:10.1111/j.1745-4514.2010.00485.x · 0.85 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Essential fatty acid (EFA) is known to be required for the body to function normally and healthily. However, the effect of EFA on glucose uptake in skeletal muscle has not yet been fully investigated. In this study, we examined the effect of two EFAs, linoleic acid (LA) and α-linolenic acid (ALA), on glucose uptake of C2C12 skeletal muscle cells and investigated the mechanism underlying the stimulatory effect of polyunsaturated EFAs in comparison with monounsaturated oleic acid (OA). In palmitic acid (PA)-induced insulin resistant cells, the co-treatment of EFAs and OA with PA almost restored the PA-induced decrease in the basal and insulin-stimulated 2-NBDG (fluorescent D-glucose analogue) uptake, respectively. Two EFAs and OA significantly protected PA-induced suppression of insulin signaling, respectively, which was confirmed by the increased levels of Akt phosphorylation and serine/threonine kinases (PKCθ and JNK) dephosphorylation in the western blot analysis. In PA-untreated, control cells, the treatment of 500 µM EFA significantly stimulated 2-NBDG uptake, whereas OA did not. Phosphorylation of AMP-activated protein kinase (AMPK) and one of its downstream molecules, acetyl-CoA carboxylase (ACC) was markedly induced by EFA, but not OA. In addition, EFA-stimulated 2-NBDG uptake was significantly inhibited by the pre-treatment of a specific AMPK inhibitor, adenine 9-β-D-arabinofuranoside (araA). These data suggest that the restoration of suppressed insulin signaling at PA-induced insulin resistant condition and AMPK activation are involved at least in the stimulatory effect of EFA on glucose uptake in C2C12 skeletal muscle cells.
    Korean Journal of Physiology and Pharmacology 06/2014; 18(3):255-61. DOI:10.4196/kjpp.2014.18.3.255 · 1.26 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In vitro examinations of the effect of saturated fatty acids on skeletal muscle insulin action often use only one or two different fatty acid species, which does not resemble the human plasma fatty acid profile. We compared graded concentrations (0.1-0.8mM) of 3 different lipid mixtures: 1) a physiologic fatty acid mixture (NORM; 40% saturated fatty acids), 2) a physiologic mixture high in saturated fatty acids (HSFA; 60% saturated fatty acids), and 3) 100% palmitate (PALM) on insulin signaling and fatty acid partitioning into triacylglycerol (TAG) and diacylglycerol (DAG) in cultured muscle cells. As expected, PALM readily impaired insulin-stimulated pAktThr308/Akt and markedly increased intracellular DAG content. In contrast, the fatty acid mixtures only modestly impaired insulin-stimulated pAktThr308M/Akt, and we found no differences between NORM and HSFA. Importantly, NORM and HSFA did not increase DAG content, but instead dose-dependently increased TAG accumulation. Therefore, the robust impairment in insulin signaling found with palmitate exposure was attenuated with physiologic mixtures of fatty acids, even with a very high proportion of saturated fatty acids. This may be explained in part by selective partitioning of fatty acids into neutral lipid (i.e., TAG) when muscle cells were exposed to physiologic lipid mixtures.
    PLoS ONE 10(3):e0120871. DOI:10.1371/journal.pone.0120871 · 3.53 Impact Factor

Full-text (2 Sources)

Available from
May 21, 2014